Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-07
2005-06-07
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S384000, C435S069100, C435S069600, C435S254100, C435S325000, C435S183000, C435S348000, C435S358000, C514S802000, C514S834000
Reexamination Certificate
active
06903069
ABSTRACT:
The present invention provides preparations of Factor VIIa polypeptides or Factor VIIa-related polypeptides that exhibit predetermined glycoform patterns. The preparations of the invention exhibit improved functional properties and are useful for treating Factor VII-mediated conditions.
REFERENCES:
patent: 4783940 (1988-11-01), Sato et al.
patent: 4784950 (1988-11-01), Hagen et al.
patent: 5580560 (1996-12-01), Nicolaisen et al.
patent: 6100061 (2000-08-01), Reiter et al.
patent: WO 01/11021 (1999-08-01), None
patent: WO 00/28065 (2000-05-01), None
Varkii, Ajit. (2001) Biochimie vol. 83, pp. 615-622.
Baker et al. (May 5, 2001) BioTechnology and BioEngineering, vol. 73, No. 3, pp. 188-202.
Tangvoranuntakul et al. (Oct. 14, 2003) Proc. Natl. Acad. Sci. vol. 100, No. 21, pp. 12045-12050.
Raju et al. (2000) Glycobiology, vol. 10, No. 55, pp. 477-486.
Jenkins, N. amd Curling, E.M.A. Glycosylation of recombinant proteins: Problems and Prospects. May 1994, Enzyme Microb. Technol. vol. 16, pp. 354-364.
Nakagaki et al. Initiation of the Extrinsic Pathway of Blood Coagulation: Evidence for the Tissue Factor Dependent Autoactivation of Human Coagulation Factor VII. Nov. 1991 Biochemistry, vol. 30, No. 45, pp. 10819-10824.
Bragonzi et al., Biochimica et Biophysica Acta, vol. 1474, pp. 273-282 (2000).
Bjoern et al., The Journal of Biological Chemistry, vol. 266, No. 17, pp. 11051-11057 (1991).
Broad et al., Cytotechnology, vol. 5, pp. 47-55 (1991).
Gawlitzek et al., Journal of Biotechnology, vol. 42, pp. 117-131 (1995).
Grabenhorst et al., Glycoconjugate Journal, vol. 16, pp. 81-97 (1999).
Jurlander et al., Seminars in Thrombosis and Hemostasis, vol. 27, No. 4, pp. 373-383 (2001).
Kemball-Cook et al., Gene, vol. 139, pp. 275-279 (1994).
Klausen et al., Molecular Biotechnology, vol. 9, pp. 195-204 (1998).
Klausen et al., Journal of Chromatography A, vol. 718, pp. 195-202 (1995).
Roddie et al., Blood Reviews, vol. 11, pp. 169-177 (1997).
Thim et al., Biochemistry, vol. 27, No. 20, pp. 7785-7793 (1988).
Weber et al., Analytical Biochemistry, vol. 225, pp. 135-142 (1995).
Weikert et al., Nature Biotechnology, vol. 17, pp. 1116-1121 (1999).
Klausen Niels Kristian
Pingel Hans Kurt
Bork Richard
Green Reza
Novo Nordisk Health Care A/S
Schnizer Holly
Smith Lan S.
LandOfFree
Factor VII glycoforms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor VII glycoforms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor VII glycoforms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3518122